We’re excited to announce the next generation of non-invasive prenatal screening, Illumiscreen, is now available in Aotearoa New Zealand from across the APHG laboratory network. Non-invasive prenatal screening (NIPS), sometimes known as NIPT, has been available for quite some time to screen fetal DNA for trisomy 21 (Down), 18 (Edward), 13 (Patau). We now have the latest […]
From October 11, 2021 the biochemistry laboratory is changing the way that LDL cholesterol (LDLC) is calculated on the lipid profile. The current calculation (Friedewald’s formula) has been in use for almost 50 years. It estimates LDLC from the total cholesterol (TC), HDL cholesterol (HDLC) and triglyceride (TG) concentrations. The calculation assumes that triglyceride-containing lipoproteins […]
We have been reviewing our laboratory processes for vaginal culture swabs. The main purpose of this test is to detect bacterial vaginosis (BV) or candidiasis in women with vaginal discharge or othersymptoms of vaginitis. The Gram stain is the gold standard investigation for both BV and candidiasis.(1-3) BV diagnosis utilises a validated scoring system based […]
Southern Community Labs and Asia Pacific Healthcare Group (APHG) are scheduling an upgrade for the reports generated for Histology, Non-gynae Cytology, Bone Marrow, Flow Cytometry and Post-Mortem tests. Read more >>
Southern Community Labs and Asia Pacific Healthcare Group (APHG) are scheduling an upgrade for rich text reports on the evening of March 25, 2021. Reformatted Bowel Screening Programme reports are included as part of this change. Read more >>